Arthroscopic Lavage Plus Corticosteroids Was More Effective Than Arthroscopic Lavage Plus Placebo or Joint Aspiration Plus Corticosteroids for Arthritis of the Knee

van Oosterhout, M.; Sont, J. K.; Bajema, I. M.; Breedveld, F. C.; van Laar, J. M.; Moseley, Bruce
May 2007
Journal of Bone & Joint Surgery, American Volume;May2007, Vol. 89-A Issue 5, p1137
Academic Journal
The article presents information on the findings of a study on the effectiveness of arthroscopic lavage plus corticosteroids, arthroscopic lavage alone, and joint aspiration plus corticosteroids in the treatment of patients with inflammatory arthritis. A randomized, partially blinded, placebo-controlled trial of 78 patients, with 9-month follow-up was conducted. It was found that arthroscopic lavage plus corticosteroids was more effective than the other two methods.


Related Articles

  • Mometasone furoate nasal spray plus oxymetazoline nasal spray: Short-term efficacy and safety in seasonal allergic rhinitis. Meltzer, Eli O.; Bernstein, David I.; Prenner, Bruce M.; Berger, William E.; Shekar, Tulin; Teper, Ariel A. // American Journal of Rhinology & Allergy;Mar/Apr2013, Vol. 27 Issue 2, p102 

    Background: Allergic rhinitis (AR) and associated congestion adversely affect patients' lives. The intranasal corticosteroid mometasone furoate nasal spray (MFNS) is effective for AR symptoms including nasal congestion, and the intranasal decongestant oxymetazoline (OXY) is effective against...

  • Treating Pemphigus Vulgaris with Prednisone and Mycophenolate Mofetil: A Multicenter, Randomized, Placebo-Controlled Trial. Beissert, Stefan; Mimouni, Daniel; Kanwar, Amrinder J.; Solomons, Neil; Kalia, Veena; Anhalt, Grant J. // Journal of Investigative Dermatology;Aug2010, Vol. 130 Issue 8, p2041 

    Non-blinded trials of pemphigus vulgaris suggest that mycophenolate mofetil (MMF) may be beneficial. In a prospective, multicenter trial, outpatients with mild or moderate pemphigus vulgaris were randomized to MMF (2 or 3 g day–1) plus oral corticosteroids or placebo plus oral...

  • Use of the Crohn's disease activity index in clinical trials of biological agents. Freeman, Hugh James // World Journal of Gastroenterology;7/14/2008, Vol. 14 Issue 26, p4127 

    The Crohn's disease activity index (CDAI) has been commonly used to assess the effects of treatment with different agents in Crohn's disease (CD). However, these studies may be compromised, if the results compared to a placebo or standard therapy group (in the absence of a placebo) substantially...

  • INTRANASAL BUDESONIDE OR FLUTICASONE FOR ALLERGIC RHINITIS. Yedavally-Yellayi, Sri Kala; French, Linda // Journal of Family Practice;Apr1999, Vol. 48 Issue 4, p248 

    The article cites a research study that analyzes which intranasal steroid, budesonide or fluticasone, is more effective in controlling symptoms of perennial allergic rhinitis. Allergic rhinitis affects from 10% to 30% of the population of the United States. Intranasal corticosteroids have become...

  • Review: Low-dose but not high-dose corticosteroids reduced all-cause mortality in severe sepsis and septic shock.  // ACP Journal Club;Mar/Apr2005, Vol. 142 Issue 2, p30 

    The article cites a survey of studies regarding the dosage of corticosteroids (CS) and its effect on the mortality in severe sepsis and septic shock. Studies were selected if they were randomized controlled trials (RCTs) or quasirandomized trials in any language and compared intravenous CSs with...

  • Cost-utility of Intravenous Immunoglobulin (IVIG) compared with corticosteroids for the treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Canada. Blackhouse, Gord; Gaebel, Kathryn; Feng Xie; Campbell, Kaitryn; Assasi, Nazila; Tarride, Jean-Eric; O'Reilly, Daria; Chalk, Colin; Levine, Mitchell; Goeree, Ron // Cost Effectiveness & Resource Allocation;2010, Vol. 8, p14 

    Objectives: Intravenous immunoglobulin (IVIG) has demonstrated improvement in chronic inflammatory demyelinating polyneuropathy (CIDP) patients in placebo controlled trials. However, IVIG is also much more expensive than alternative treatments such as corticosteroids. The objective of the paper...

  • Salmeterol Compared with Current Therapies in Chronic Asthma. Adinoff, Allen D.; Schwartz, Howard J.; Richard, Kathleen A.; Yancey, Steven W.; Swearingen, Blake E. // Journal of Family Practice;Oct1998, Vol. 47 Issue 4, p278 

    BACKGROUND. Therapy with salmeterol, a long-acting, selective, inhaled β2-adrenergic agonist, is effective and safe for patients with persistent asthma; however, few long-term studies comparing salmeterol with current combination treatment regimens have been reported. METHODS. A multicenter,...

  • Efficacy and safety of infliximab-biosimilar compared to other biological drugs in rheumatoid arthritis: a mixed treatment comparison. Baji, Petra; Péntek, Márta; Czirják, László; Szekanecz, Zoltán; Nagy, György; Gulácsi, László; Brodszky, Valentin // European Journal of Health Economics;May2014 Supplement, Vol. 15, p53 

    Objective: The aim of this meta-analysis was to compare the efficacy and safety of infliximab-biosimilar and other available biologicals for the treatment of rheumatoid arthritis (RA), namely abatacept, adalimumab, certolizumab pegol, etanercept, golimumab, infliximab, rituximab and tocilizumab....

  • UCB reports positive results from two Phase III arthritis trials.  // PharmaWatch: Biotechnology;Jan2009, Vol. 8 Issue 1, p7 

    The article reports on the results of two Phase III studies made by UCB in the U.S. The studies revealed that Cimzia, the only PEGylated anti-TNFalpha, provided significant clinical benefits as monotherapy, and in combination with methotrexate, in adults with active rheumatoid arthritis....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics